These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1479217)

  • 21. [Primary hyperlipoproteinemia type 3].
    Watanabe A; Mabuchi H; Takeda R
    Nihon Rinsho; 1983 Aug; 41(8):1804-9. PubMed ID: 6579323
    [No Abstract]   [Full Text] [Related]  

  • 22. [Remnant disease associated with apoprotein E1; clinical importance of apoprotein E (apo E) phenotypes].
    Borghini I; James RW; Pometta D
    Schweiz Med Wochenschr; 1989 Dec; 119(50):1821-4. PubMed ID: 2609136
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Catabolism of very-low-density lipoproteins in subjects with broad beta disease: comparison with endogenous hypertriglyceridemia.
    Kushwaha RS; Chait A; Hazzard WR
    J Lab Clin Med; 1982 Jan; 99(1):15-24. PubMed ID: 6948063
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Familial type III hyperlipoproteinemia].
    Kataoka S; Egusa G
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():69-73. PubMed ID: 11347154
    [No Abstract]   [Full Text] [Related]  

  • 25. [Specific diagnosis of familial dysbetalipoproteinemia in Denmark. Report of a family study].
    Gerdes LU; Faergeman O
    Ugeskr Laeger; 1988 Jan; 150(4):230-2. PubMed ID: 3376331
    [No Abstract]   [Full Text] [Related]  

  • 26. A young type III hyperlipoproteinemic patient associated with apolipoprotein E deficiency.
    Mabuchi H; Itoh H; Takeda M; Kajinami K; Wakasugi T; Koizumi J; Takeda R; Asagami C
    Metabolism; 1989 Feb; 38(2):115-9. PubMed ID: 2492364
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic heterogeneity of apolipoprotein E and its influence on plasma lipid and lipoprotein levels.
    de Knijff P; van den Maagdenberg AM; Frants RR; Havekes LM
    Hum Mutat; 1994; 4(3):178-94. PubMed ID: 7833947
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Simple precipitation-based method for the screening of type III hyperlipoproteinemia.
    Nauck M; Glatt L; März W; Feussner G; Wieland H
    Clin Chem; 1999 Jun; 45(6 Pt 1):909-11. PubMed ID: 10352005
    [No Abstract]   [Full Text] [Related]  

  • 29. [Hyperlipoproteinemia type III: genetic basis and environmental factors, diagnosis, and treatment].
    Pocoví M; Garcés C; Casao E; Cenarro A; Civeira F
    Rev Clin Esp; 1992 Nov; 191(8):444-50. PubMed ID: 1488520
    [No Abstract]   [Full Text] [Related]  

  • 30. Severe type III hyperlipoproteinemia in two patients maintained on chronic hemodialysis.
    Feussner G; Bommer J; Ziegler R
    Klin Wochenschr; 1990 Jan; 68(2):65-70. PubMed ID: 2319734
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Apolipoproteins and atherosclerosis--study of apolipoprotein E].
    Taniguchi T; Yamasaki S
    Rinsho Byori; 1984 Jul; 32(7):772-9. PubMed ID: 6389939
    [No Abstract]   [Full Text] [Related]  

  • 32. [Apolipoprotein E deficiency associated with type III hyperlipoproteinemia--analysis of apolipoprotein E].
    Tsukamoto H; Hirose H; Dan K; Ishii K; Kikuchi H; Murata M
    Rinsho Byori; 2006 Feb; 54(2):121-5. PubMed ID: 16548231
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Genetic variants of apo E: significance for triglyceride metabolism].
    Mann WA; Brewer HB; Greten H
    Z Gastroenterol Verh; 1991 Mar; 26():106. PubMed ID: 1714116
    [No Abstract]   [Full Text] [Related]  

  • 34. Genetics of type III hyperlipoproteinemia.
    Feussner G; Piesch S; Dobmeyer J; Fischer C
    Genet Epidemiol; 1997; 14(3):283-97. PubMed ID: 9181357
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A study of the hypolipidemic effect of estrogen in type III hyperlipoproteinemia.
    Stuyt PM; Demacker PN; van't Laar A
    Horm Metab Res; 1986 Sep; 18(9):607-10. PubMed ID: 3465673
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of infusion of normal plasma on lipoproteins in type III hyperlipoproteinemia.
    Stuyt PM; Demacker PN; van 't Laar A
    Horm Metab Res; 1981 Dec; 13(12):715-6. PubMed ID: 7319472
    [No Abstract]   [Full Text] [Related]  

  • 37. [Genetic aspects of arteriosclerosis].
    Maciołowski M
    Przegl Lek; 1983; 40(10):743-7. PubMed ID: 6364256
    [No Abstract]   [Full Text] [Related]  

  • 38. [Homogenous low-density lipoprotein assay in type III hyperlipoproteinemia].
    Waki M; Amano T
    Rinsho Byori; 2000 Dec; 48(12):1164-7. PubMed ID: 11215427
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Xanthoma striatum palmare as an early sign of familial type III hyperlipoproteinemia with an apoprotein E genotype epsilon2/epsilon2.
    Sato-Matsumura KC; Matsumura T; Yokoshiki H; Chiba H; Shimizu H
    Clin Exp Dermatol; 2003 May; 28(3):321-2. PubMed ID: 12780724
    [No Abstract]   [Full Text] [Related]  

  • 40. Variable expression of familial dysbetalipoproteinemia in apolipoprotein E*2 (Lys146-->Gln) Allele carriers.
    de Knijff P; van den Maagdenberg AM; Boomsma DI; Stalenhoef AF; Smelt AH; Kastelein JJ; Marais AD; Frants RR; Havekes LM
    J Clin Invest; 1994 Sep; 94(3):1252-62. PubMed ID: 8083367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.